Related Experiment Videos
Severe pyruvate kinase deficiency anemia. A case report
1Perinatal Diagnostic Center, Alexandria Hospital, Virginia, USA.
The Journal of Reproductive Medicine
|September 28, 1998
Summary
Severe pyruvate kinase deficiency anemia in pregnancy may not require prophylactic blood transfusions. Conservative management can lead to good perinatal outcomes, challenging traditional treatment thresholds.
Area of Science:
- Hematology
- Obstetrics
- Genetics
Background:
- Pyruvate kinase deficiency (PKD) is a rare genetic disorder causing hemolytic anemia.
- Severe PKD often necessitates splenectomy in childhood and, during pregnancy, traditional management involves prophylactic blood transfusions.
Observation:
- A case study explored conservative management of severe PKD anemia during pregnancy.
- The patient's hemoglobin reached a nadir of 6.8 g/dL without blood transfusions.
Findings:
- Conservative management resulted in a good perinatal outcome.
- Pregnancy itself may not be an absolute indication for prophylactic transfusions in severe PKD.
Implications:
- This challenges the conventional approach to managing severe PKD during pregnancy.
- It suggests a potential shift towards less invasive strategies, prioritizing maternal and fetal well-being without unnecessary interventions.